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Abstract
Background: Chromatin immunoprecipitation coupled with high-throughput DNA sequencing (ChIP-seq) offers
high resolution, genome-wide analysis of DNA-protein interactions. However, current standard methods require
abundant starting material in the range of 1–20 million cells per immunoprecipitation, and remain a bottleneck to
the acquisition of biologically relevant epigenetic data. Using a ChIP-seq protocol optimised for low cell numbers
(down to 100,000 cells / IP), we examined the performance of the ChIP-seq technique on a series of decreasing cell
numbers.
Results: We present an enhanced native ChIP-seq method tailored to low cell numbers that represents a 200-fold
reduction in input requirements over existing protocols. The protocol was tested over a range of starting cell
numbers covering three orders of magnitude, enabling determination of the lower limit of the technique. At low
input cell numbers, increased levels of unmapped and duplicate reads reduce the number of unique reads
generated, and can drive up sequencing costs and affect sensitivity if ChIP is attempted from too few cells.
Conclusions: The optimised method presented here considerably reduces the input requirements for performing
native ChIP-seq. It extends the applicability of the technique to isolated primary cells and rare cell populations
(e.g. biobank samples, stem cells), and in many cases will alleviate the need for cell culture and any associated
alteration of epigenetic marks. However, this study highlights a challenge inherent to ChIP-seq from low cell
numbers: as cell input numbers fall, levels of unmapped sequence reads and PCR-generated duplicate reads rise.
We discuss a number of solutions to overcome the effects of reducing cell number that may aid further
improvements to ChIP performance.
Keywords: PCR duplicates, Redundant reads, HTS, NGS, Next generation sequencing, Micro-ChIP, N-ChIP, Native
ChIP, Location analysis, Histone
Background
Chromatin immunoprecipitation (ChIP) is used to deter-
mine the genomic interaction sites between nuclear pro-
teins and nucleic acids. Standard ChIP protocols used
for genome-wide studies typically require large quan-
tities of starting material, in the range of 107 cells. The
amount of material immunoprecipitated varies depend-
ing on the target protein and antibody employed, but is
usually in the range of a few hundred picograms to tens
of nanograms.
Over the past decade, genome-wide analysis of
ChIP material has been possible by employing whole
genome amplification techniques to produce microgram
quantities of DNA for hybridisation to microarrays,
commonly referred to as ChIP-chip. Recently, the
application of high-throughput sequencing (HTS) to
analyse the immunoprecipitates, commonly referred to
as ChIP-seq, has replaced ChIP-chip as the preferred
means of harvesting genome-wide data, and confers a
number of advantages including higher resolution,
improved quantification range, greater genome coverage,
fewer artifacts, and lower cost [1]. However, the library
preparation methods required to render immunoprecipi-
tated DNA ready for HTS sequencing involve inefficient
enzymatic steps and multiple purifications, each
* Correspondence: gregor.gilfillan@medisin.uio.no; robert.lyle@medisin.uio.no
1Department of Medical Genetics, Oslo University Hospital, Oslo, Norway
Full list of author information is available at the end of the article
© 2012 Gilfillan et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Gilfillan et al. BMC Genomics 2012, 13:645
http://www.biomedcentral.com/1471-2164/13/645
resulting in sample loss. As a result, ChIP-seq requires a
similar starting amount of immunoprecipitated DNA
(1–10 ng) to ChIP-chip, and nonetheless involves many
cycles of PCR (typically 15–18 cycles). These limitations
mean that it is still challenging to apply ChIP-seq to low
numbers of cells.
There have been several recent papers detailing ChIP
protocols applicable to low cell numbers (down to 100
cells) based on the inclusion of carrier DNA [2] or
improvements in the efficiency of the immunoprecipita-
tions themselves [3-7]. However, these techniques have
been limited to locus-specific analysis of the precipitates
by quantitative PCR. By incorporating whole genome
amplification (WGA) methods, these techniques have
been extended to allow genome-wide analysis by ChIP-
chip from as few as 10,000 cells [8] or 1,000 cells [9].
Three recent publications detail the development of
ChIP-seq protocols for use with low cell numbers, all
based on formaldehyde crosslinked chromatin: Using
standard Illumina library preparation procedures,
Hitchler & Rice demonstrated ChIP-seq from 1 × 106 hu-
man stem cells and 5 ng immunoprecipitated DNA [10].
Greater reductions have been possible using alternative
library preparation methods, where cell requirements
have been lowered to 10,000 [11] (the method is also
presented in more detail elsewhere [12]), and even 5000
[13], with input DNA amounts below 50 pg. However,
these methods employ either lengthy linear amplification
procedures, or primer extension (4 cycles) and 15 cycles
of PCR – all prior to a standard Illumina library prep
entailing a further 17–18 cycles of PCR.
An alternative method of performing ChIP avoids the
use of formaldehyde cross-linking and is thus known as
native ChIP (N-ChIP) [14-17]. The advantages of N-
ChIP over cross-linked ChIP (X-ChIP) include higher
resolution, and lack of unspecific interaction caused by
formaldehyde crosslinking. It has also been suggested
that the N-ChIP method is more sensitive than X-ChIP,
as epitopes may not be masked by cross-linked proteins
or be themselves denatured by formaldehyde [15] mak-
ing N-ChIP ideally suited to studies aiming to examine
small cell numbers. However, N-ChIP is generally con-
sidered only applicable to histone proteins, although
successful N-ChIP of MeCP2 [18] and a handful of tran-
scription factors including Runx2, Dlx6 and Sin3a have
been reported [19].
We present here an N-ChIP method for genome-wide
analysis by ChIP-seq, optimised for use with low starting
cell numbers (here 200,000, divided into two im-
munoprecipitations of 100,000 each). This demonstrates
ChIP-seq with 200-times fewer cells than a previously
published method used as a benchmark for comparison.
The performance of the optimised method was evaluated
for read mapping, sensitivity and specificity at a range of
starting cell numbers covering three orders of magnitude,
starting with the published amount of 2 × 107 cells / IP
and reduced to a point where sensitivity was compro-
mised, to determine the limits of the technique.
Results
The ChIP method described here was developed using
the N-ChIP method of Zhao and colleagues [20,21] as a
starting point. We therefore set the existing technique,
using the published amount of 2 × 107 cells per immu-
noprecipitation, as a benchmark against which to com-
pare the performance of our method at a series of
decreasing cell numbers. The new method presented
here significantly shortens the procedure by eliminating
the need for dialysis, and incorporates modifications
optimised for low cell numbers.
Chromatin prepared using the two methods was pre-
pared from cultured CD4+ lymphocytes, and immuno-
precipitated with anti-H3K4me3 antibody. Enrichment
at positive and negative control loci (see methods sec-
tion) was measured by quantitative PCR prior to gener-
ation of Illumina sequencing libraries. Each ChIP-seq
library was then sequenced on a single lane of an Illu-
mina GAIIx sequencer, and generated chromatin profiles
typical of H3K4 trimethylation, from which peaks were
called. At this point it was determined that additional se-
quencing was required to saturate peak calling (see
below) in the lowest cell number employed, so additional
sequencing was performed for this sample using a single
lane of an Illumina HiSeq 2000 machine.
The total number of reads generated for each library
and the results of aligning these libraries to the human
genome are summarized in Figure 1. As cell numbers
are reduced, the number of unmapped reads increases.
In addition, the percentage of mapped reads derived
from duplicate reads increases. A sample of unmapped
reads was aligned against the GenBank nucleotide data-
base [22] using blast [23]. The results showed that a
small proportion of unmapped reads in all cases repre-
sent those containing sequencing errors that fail to map
to the human genome (the BWA algorithm does not tol-
erate more than 2 mismatches in its 32 bp seed). The re-
mainder of unmapped reads, which increase with
decreasing input cell number, fail to map with high con-
fidence to any sequence in the GenBank database and
are apparently PCR amplification artifacts. The increased
level of duplicate reads seen at lower cell numbers is also
assumed to be introduced during the PCR amplification
(18 cycles) required as part of Illumina library prepar-
ation. The same number of PCR cycles were applied to
each sample, to facilitate inter-sample comparisons. A
disadvantage of this approach is that a greater number
of cycles than necessary to generate sufficient library to
sequence, were applied to the higher cell number
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samples. Despite this, only in the low cell number sam-
ples did the decreased amount and complexity of the in-
put material, lead to high proportions of duplication
during amplification.
ChIP-seq profiles from each experiment can be seen in
Figure 2a and 2b, and by visual inspection, peaks of
H3K4me3 can be seen to occupy promoter regions as
expected from previous studies [24]. To demonstrate the
increased sensitivity of the new method relative to
the benchmark, an additional profile generated using the
benchmark at a low cell number is shown (Figure 2a and
2b). The resolution afforded by the MNase digestion
allows identification of individual nucleosome positions
(Figure 2b). The relationship between H3K4me3 and
transcription start sites (TSS) was confirmed by plotting
H3K4me3 levels relative to transcription start sites
(Figure 2c), which reproduces earlier findings showing
depletion of histones at the TSS itself, and a series of
clearly positioned nucleosomes upstream and down-
stream [20]. Furthermore, immunoprecipitation with
H3K4me3 is strongest at highly expressed genes, and
diminishes with decreasing expression level (Figure 2c).
To define genomic regions of H3K4 trimethylation,
peak calling was performed using MACS [26], using only
uniquely mapping, non-duplicate reads. Performing peak
calling whilst including duplicate reads led to the ap-
pearance of high numbers of non-specific peaks,
particularly in the lowest cell number sample (data not
shown). Calling peaks when correcting for background
control (sequencing libraries prepared from each sam-
ple’s ChIP input DNA) made negligible difference to the
number of peaks recognised; 0.03 – 1.43% of peaks were
no longer called when using a control dataset. The total
number of peaks called for each cell number is summar-
ized in Table 1. The number of peaks called falls appre-
ciably only at the lowest cell input number tested, to
below 75% of the number called in the benchmark. Cru-
cially, despite the lower numbers of uniquely mapped
reads recovered from the lowest cell number sample,
peak calling was saturated for all samples: When de-
creasing proportions of total available reads were used
to call peaks (Figure 3a), the absence of a reciprocal rela-
tionship between read count and peaks called indicates
that all samples are approaching saturation (i.e. where
adding more reads will not increase the number of peaks
called). Therefore, the lower number of peaks called
using only 20,000 cells / IP is due to the reduced num-
ber of useful reads (non duplicated and uniquely map-
ping) available as cell numbers fall, and not simply
because more sequencing is required.
Using the method of Zhao and colleagues as a bench-
mark, the overlap with peaks called from the new
method was evaluated as a measure of sensi-
tivity (Table 1). Sensitivity was well maintained down to
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Figure 1 Genomic mapping of sequence reads. The proportion of reads that were unmapped, those mapping to single genomic positions,
and those mapping to multiple locations (repeats) are illustrated. The latter two categories are broken down into reads present as a unique copy,
or those reads that are present in two or more identical copies (duplicates). The total number of reads generated for each experimental
condition are given at the right.
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1 × 105 cells / IP, where 85% of peaks could still be
detected. As expected from the reduced number of
peaks called, sensitivity fell in the lowest cell number
sample to 70%. Peaks were not lost randomly with
reduced cell numbers. Rather, the same peaks were
affected in each sample, with the preferential loss of
those with lowest significance (fewest reads) evident as
cell numbers were reduced.
Importantly, peak position was not adversely affected
by lowering cell number. As can be seen in Figure 3b,
peak overlaps between the benchmark and other data-
sets were close to 100% (i.e. not partially overlapping, or
within an arbitrarily chosen window size). However, peak
width was reduced in the lowest cell number samples
(Figure 3c). Whilst every effort was made to ensure simi-
lar MNase digestion between the samples, we cannot ex-
clude that the narrower peaks seen with lower cell
numbers are due to increased digestion in these samples.
However, the effect may be entirely explained by the
lower number of reads available for peak calling in these
samples. We are currently unable to separate the two
possibilities.
In addition, extra peaks not present in the benchmark
dataset were used to calculate a measure of specificity
(Table 1). Specificity was not affected by scaling down
cell numbers, with all datasets having greater than 90%
of called peaks “on target” when comparing to the
benchmark. It should be noted that this assumes that
the dataset of Zhao and colleagues represents a gold
standard and that additional peaks are false positives,
which is not necessarily the case. Comparing the signal
intensity of peaks at each location revealed a strong
correlation, which deteriorated at the lowest cell number
of 2 × 104 cells per IP (Figure 3d).
To demonstrate the application of the new method to
other histone modifications, the transcriptionally repres-
sive H3K27me3 mark was also examined. Figure 4a
shows the ChIP-seq profile of H3K4me3 and H3K27me3
generated from 100,000 cells / IP at the active STAT4
and inactive MYO1B loci (a comparable image can be
found in the paper of Barski et al., [20]). The mutually
exclusive nature of H3K4 and H3K27 trimethylation is
clearly visible in these profiles.
To assess the reproducibility of data generated with
the new method, three independent chromatin extracts
were prepared from frozen primary CD4+ lymphocytes,
from which H3K4me3 and H3K27me3 ChIP-seq profiles
were generated using 100,000 and 20,000 cells per IP. A
heatmap display allowing comparison of the read depths
across all 12 samples is presented in Figure 4b, and
shows the similarity of the replicate samples across an
8 Mb chromosomal section. The mutually-exclusive na-
ture of the two histone modifications is also clearly vis-
ible at this scale. A quantitative measure of pairwise
ChIP signal intensities (Pearson0s correlation coefficient)
is shown for selected replicate pairs in Figure 4c-f, and a
complete matrix of correlation coefficients is provided as
Table 2. Correlation coefficients are high for both
H3K4me3 and H3K27me3 datasets from 100,000 cells/ IP,
and drop when 20,000 cells were used, supporting
our earlier observations that the sensitivity of the tech-
nique is adversely affected at this low level of input ma-
terial. The mutually exclusive nature of H3K4 and
H3K27 trimethylation is confirmed here by the negative
(See figure on previous page.)
Figure 2 H3K4me3 peaks are found at promoters, where peak heights parallel gene expression levels. (a) 330 kb section of the
gene-dense major histocompatibility complex (MHC) visualised in the Integrative Genomics Viewer [25]. Tracks display read depth for benchmark
(gray) and new (black) ChIP methods at decreasing input cell numbers. Maximum read depth over the displayed area is indicated on the right
of each track. Only uniquely mapping, non-duplicate reads are displayed. (b) 8 kb region showing H3K4me3 signal over the promoter of the
RPL30 gene. (c) Sequence coverage over transcription start sites (TSS). Coverage is displayed as a function of gene expression, with genes divided
into quartiles based on expression level.
Table 1 Peak calling, sensitivity (detection of peaks called in the benchmark) and specificity (off-target peaks not
present in the benchmark)
Protocol & cell number / ChIP Bench’ New New New New New
2 x 107 2 x 107 2.5 x 106 5 x 105 1 x 105 2 x 104
Total number reads 13 402 262 13 798 839 14 136 243 16 693 519 15 601 563 56 904 707
Number unique, non-duplicate reads 6 011 891 7 0330 709 5 794 519 3 463 886 2 423 126 661 591
Number of peaks called (fraction relative to benchmark) 16 545 16 244 17 054 15 636 14 771 12 296
(1) (0.98) (1.03) (0.95) (0.89) (0.74)
Sensitivity relative to benchmark 1 0.93 0.96 0.89 0.85 0.69
Specificity relative to benchmark 1 0.94 0.93 0.95 0.97 0.98
Peaks were called using MACS, allowing no ambiguously mapping or duplicate reads.
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correlations seen when comparing these datasets. Four
ChIP-seq datasets from the ENCODE project [27] have
been included for comparison (two replicates each of
H3K4me3 and H3K27me3 from the lymphoblastoid cell
line GM12878 [28]), and show similar or poorer correl-
ation coefficients than the datasets generated here from
100,000 cells / IP (Table 2).
Finally, to demonstrate the utility of the method using
primary cell isolates, we applied it to cell samples from
three pairs of human monozygotic twins. Using purified
and live-frozen CD4+ and CD8+ lymphocytes (in the
range of 365–500,000 cells per IP), H3K4 trimethylation
profiles were prepared from each individual. A rudimen-
tary comparison of peak calling in the three twin pairs is
included here to demonstrate application of the method
to primary cell isolates (Table 3). Peaks were considered
concordant between a twin pair if peaks called in both
individuals overlapped. Peak concordance ranged from
82–94% in CD4+ cells and 73–78% in CD8+ lympho-
cytes. A more complete analysis of several twin pairs,
aimed at identifying differential methylation between
twins, is outside the scope of this manuscript and will be
presented elsewhere.
Discussion
In this study we have developed and employed a rapid
N-ChIP technique applicable to small cell numbers,
which functions well down to 100,000 cells / IP. Whilst
this limit is higher than the requirements reported using
alternative HTS library preparation methods [11-13], it
minimizes the use of nucleic acid amplification and asso-
ciated risk of bias in the data. As the first N-ChIP proto-
col tailored to low cell numbers, it therefore offers an
attractive alternative method to map the genome-wide
distribution of histone modifications. The success of the
method using standard HTS library preparation techni-
ques may reflect the reported higher efficiency of N-chip
relative to X-ChIP [15]. We would also like to stress the
importance of selecting specific antisera, such as using a
peptide array as employed here, to the success of this or
any ChIP protocol using low input cell numbers. We
have demonstrated the application of this method to
immuno-purified CD4+ and CD8+ primary lymphocytes,
thus avoiding the need for cell culture, which risks alter-
ing epigenetic modifications. Nonetheless, the study
highlights the need for careful monitoring of sequence
read mapping in the analysis of ChIP-seq data from lim-
ited cell numbers, to identify sources of wasted reads
and ensure sufficient coverage for reliable peak calling.
As demonstrated here, PCR amplification from limited
ChIP input material led to a reduction of mappable
and unique reads through losses to amplification arti-
facts and duplicate molecules, which must be removed
for reliable peak calling. The accumulation of such
undesirable amplification artifacts in alternative techni-
ques such as LinDA and nano-ChIP-seq [11-13] has not
been adequately addressed to date, and requires further
examination. Notably, the method presented here entails
fewer amplification cycles than these other techniques.
The introduction of bias by genome-amplification tech-
niques such as linker-mediated PCR and WGA have
been documented [29]. It is therefore desirable to min-
imise the number of amplification cycles whenever pos-
sible. It is likely that the levels of PCR artifacts could be
reduced by employing alternative amplification condi-
tions, or through the use of alternative polymerases.
It has been shown that both MNase digestion and son-
ication demonstrate some DNA cleavage sequence pre-
ference, which necessitates the use of control digestion /
sonication of naked DNA when interpreting HTS data
with the aim of identifying nucleosome positions or
regions of high accessibility such as promoters [30,31].
The existence of favourable cleavage sites will inevitably
lead to a number of “duplicate” reads that are in fact
biological in origin rather than amplification artifacts.
This effect is likely to be more pronounced in MNase
digested chromatin, as the preferential digestion of
MNase in inter-nucleosomal linker regions further
restricts genomic cleavage sites. It is therefore possible
that the levels of duplication seen here will not be so
high when using formaldehyde cross-linked chromatin,
although this remains to be tested. Using the data pre-
sented here, inclusion of duplicate reads led to the ap-
pearance of many non-specific peaks, so it remains
challenging to differentiate genuine biological duplicate
reads from those arising as the result of the PCR
process. The percentage of duplicate reads derived from
PCR could be further reduced by employing paired-end
reads rather than the single reads typically used, as here,
for ChIP-seq analysis. Only in the situation where mole-
cules have exactly the same length and genomic pos-
ition, would paired reads be counted as a duplicate.
Alternatively, utilizing multiple combinations of indexed
adapters, termed digital sequencing [32], would allow
the differentiation of biological and PCR-derived dupli-
cate reads.
In addition to the problems of amplification artifacts
and duplicate reads, ChIP-seq from limiting cell num-
bers is challenging due to the reduced complexity of
immunoprecipitated material recovered. In the case of
CD4+ cells presented here, sensitivity and reproducibility
were not badly affected down to 100,000 cells / IP, but
below this were reduced, although useful results were
nonetheless obtained (70% of peaks detected by bench-
mark method). Further improvements are likely possible
by increasing the efficiency of immunoprecipitation,
DNA purification, and sequencing library generation
methods.
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Figure 3 Saturation, sensitivity and correlation of peak calling with decreasing cell number. (a) Saturation of peak calling as reads are
randomly discarded. Peaks were called using only unique non-duplicated reads. (b) Overlap of called peaks in the different datasets with
benchmark dataset peaks. Inset diagram defines examples of full or partial peak overlap, with the upper bar in each case representing the
benchmark. Colours as in panel a. (c) Coverage of benchmark peaks by peaks in other datasets. Colours as in panel a. Inset shows examples of
coverage, with upper bar in each case representing the benchmark. (d) Correlation of peak heights between benchmark and new sample
datasets. Spearman correlation coefficients (ρ) are given. Only peaks overlapping a benchmark peak were included in this analysis. The number of
reads in a given peak was normalised to the total number of reads (uniquely mapping non-duplicated) in the sample.
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Figure 4 Reproducibility of H3K4me3 and H3K27me3 ChIP-seq with the new method. (a) 1Mb region of chromosome 2 containing the
transcriptionally active STAT1 / 4 and inactive MYO1B loci, visualised in the IGV genome browser. (b) Heatmap display in IGV genome browser
showing triplicate ChIP signals over an 8 Mb region on chromosome 12. H3K27me3 and H3K4me3 signals are shown for 50 and 10 kb window
sizes respectively. (c-f) Genome-wide pairwise correlations of read depth in 50 kb (H3K27me3) and 10 kb (H3K4me3) bins for selected replicate
samples. Pearson correlation coefficients are given for each comparison. Read depth per bin was normalised to the total number of uniquely
mapping reads per sample (reads per bin per million uniquely mapped reads).
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The future adoption of epigenetic analyses in research
and diagnostic procedures will require techniques that
allow analysis of specific cell types, sub-populations and
small biopsy samples. For example, the N-ChIP technique
has been optimised for analysis of the Schistosoma parasite
[33], and techniques have been developed for ChIP from
particular structures such as the hippocampus [34]. We
have demonstrated here the application of the enhanced
method to lymphocytes isolated from human twins. The
cells used for study were enriched using antibody-driven
magnetic cell sorting, derived from a starting material
of 10–20 mls blood. It would not have been possible
to study such small, easily obtained biological samples
using previously published N-ChIP procedures. Further
Table 2 Genome-wide pairwise correlation coefficients of replicate ChIP experiments
GM GM GM GM H3 H3 H3 H3 H3 H3 H3 H3 H3 H3 H3 H3
H3 H3 H3 H3 K27 K27 K27 K27 K27 K27 K4 K4 K4 K4 K4 K4
K27 K27 K4 K4 me3 me3 me3 me3 me3 me3 me3 me3 me3 me3 me3 me3
me3 me3 me3 me3 100k 100k 100k 20k 20k 20k 100k 100k 100k 20k 20k 20k
R1 R2 R1 R2 R1 R2 R3 R1 R2 R3 R1 R2 R3 R1 R2 R3
GM H3K27 me3 R1 1.00 0.86 0.07 −0.02 0.70 0.70 0.70 0.70 0.69 0.69 −0.05 −0.05 −0.05 0.01 0.02 0.06
GM H3K27 me3 R2 0.86 1.00 0.17 0.16 0.74 0.70 0.72 0.72 0.73 0.70 0.04 0.05 0.05 0.09 0.10 0.12
GM H3K4 me3 R1 0.07 0.17 1.00 0.95 0.01 0.02 0.01 0.02 0.02 0.03 0.68 0.67 0.69 0.57 0.63 0.51
GM H3K4 me3 R2 −0.02 0.16 0.95 1.00 0.00 −0.01 −0.01 0.00 0.01 0.00 0.72 0.71 0.74 0.59 0.64 0.49
H3K27me3 100k R1 0.70 0.74 0.01 0.00 1.00 0.95 0.97 0.96 0.96 0.94 −0.09 −0.09 −0.09 −0.06 −0.06 −0.03
H3K27me3 100k R2 0.70 0.70 0.02 −0.01 0.95 1.00 0.94 0.94 0.93 0.92 −0.09 −0.09 −0.09 −0.05 −0.05 −0.01
H3K27me3 100k R3 0.70 0.72 0.01 −0.01 0.97 0.94 1.00 0.95 0.95 0.93 −0.09 −0.09 −0.09 −0.05 −0.05 −0.02
H3K27me3 20k R1 0.70 0.72 0.02 0.00 0.96 0.94 0.95 1.00 0.95 0.93 −0.09 −0.09 −0.09 −0.05 −0.05 −0.02
H3K27me3 20k R2 0.69 0.73 0.02 0.01 0.96 0.93 0.95 0.95 1.00 0.93 −0.08 −0.08 −0.08 −0.04 −0.04 −0.01
H3K27me3 20k R3 0.69 0.70 0.03 0.00 0.94 0.92 0.93 0.93 0.93 1.00 −0.08 −0.09 −0.09 −0.04 −0.04 0.00
H3K4me3 100k R1 −0.05 0.04 0.68 0.72 −0.09 −0.09 −0.09 −0.09 −0.08 −0.08 1.00 0.86 0.88 0.70 0.76 0.59
H3K4me3 100k R2 −0.05 0.05 0.67 0.71 −0.09 −0.09 −0.09 −0.09 −0.08 −0.09 0.86 1.00 0.87 0.69 0.76 0.59
H3K4me3 100k R3 −0.05 0.05 0.69 0.74 −0.09 −0.09 −0.09 −0.09 −0.08 −0.09 0.88 0.87 1.00 0.70 0.77 0.58
H3K4me3 20k R1 0.01 0.09 0.57 0.59 −0.06 −0.05 −0.05 −0.05 −0.04 −0.04 0.70 0.69 0.70 1.00 0.66 0.56
H3K4me3 20k R2 0.02 0.10 0.63 0.64 −0.06 −0.05 −0.05 −0.05 −0.04 −0.04 0.76 0.76 0.77 0.66 1.00 0.60
H3K4me3 20k R3 0.06 0.12 0.51 0.49 −0.03 −0.01 −0.02 −0.02 −0.01 0.00 0.59 0.59 0.58 0.56 0.60 1.00
Pearson0s correlation coefficients for all pairwise sample comparisons were calculated for read depth across the genome divided into 50 kb (H3K27me3) or 10 kb
(H3K4me3) non-overlapping bins. Replicate datasets derived from 100,000 cells / IP (100k) and those from 20,000 cells / IP (20k) are denoted by suffixes R1- R3.
For comparison, four ENCODE datasets (two replicates each of H3K27me3 and H3K4me3) from the cell line GM12878, a lymphoblastoid cell line, have been
included (GM; replicates denoted by R1 and R2).
Table 3 ChIP-seq from primary cells isolated from human monozygotic twins
Twin Pair Twin pair 1 Twin pair 2 Twin pair 3
CD4+ cells
Cell no. / IP 5 x 105 5 x 105 5 x 105 5 x 105 5 x 105 5 x 105
No. reads 35 244 517 44 255 574 40 644 508 45 738 891 38 332 819 29 484 478
No. unique, nonduplicate reads 3 978 339 6 524 094 3 316 312 3 340 926 3 130 804 1 167 824
No. Peaks called 14 828 12 622 15 598 15 731 15 825 13 719
No. overlapping peaks (%) 12 457 (82%) 14 833 (94%) 13 091 (83%)
CD8+ cells
Cell no. / IP 4.3 x 105 3.7 x 105 4.7 x 105 5 x 105 3.8 x 105 4.2 x 105
No. reads 45 245 361 35 681 254 38 455 042 35 257 788 34 505 357 41 729 689
No. unique, nonduplicate reads 18 996 309 4 778 486 12 403 566 6 654 203 5 840 308 4 438 574
No. Peaks called 17 704 18 720 20 728 18 145 18 743 20 899
No. overlapping peaks (%) 14 578 (78%) 18 828 (76%) 15 312 (73%)
Peaks were called using MACS, allowing no ambiguously mapping or duplicate reads. Peaks with p-values > 1x10-10 were excluded from analysis. Numbers of
overlapping peaks were counted, and expressed as a percentage of the highest peak count for the twin pair.
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improvements in both ChIP protocols and HTS library
preparation methods, such as single molecule sequencing
[35] promise to increase the possibilities for epigenetic
studies from these and other challenging samples.
Conclusions
Using an enhanced native ChIP-seq method, we have
detailed known but hitherto uncharacterised problems of
performing ChIP-seq from limited cell numbers. Using
our method, high quality results were obtained from
200,000 cells starting material (using 100,000 cells per IP),
increasing possibilities for the study of rare cell popula-
tions and biopsy samples without the need for cell culture.
It was possible to generate results from as low as 20,000
cells per IP, but at a cost to sensitivity, where only 70% of
known peaks could be detected, so we declare the limit of
this method to currently require 100,000 cells per IP. This
method offers an alternative to other previously published
methods for low cell number ChIP-seq that entails fewer
cycles of amplification with associated risk of data bias.
Nonetheless, as cell numbers are reduced, the amount and
complexity of immunoprecipitated material is reduced.
Amplification of this material leads to a corresponding rise
in PCR duplicates and unmapped reads, which may neces-
sitate costly additional sequencing, an effect that requires
further characterisation in comparable methods. Add-
itional improvements in the efficiency of immunoprecipi-
tation and HTS library generation techniques are desirable
to bring us closer to the goal of single cell analysis.
Methods
Isolation of lymphocyte sub-populations & cell culture
Peripheral blood mononuclear cells (PBMCs) were iso-
lated from an anonymous human blood donor using Lym-
phoprep reagent (Axis-Shield plc, Dundee, UK). CD8+
and CD4+ cells were sequentially isolated using an Auto-
MACS Pro separator (Miltenyi Biotec, Köln, Germany) by
positive and negative isolation, respectively. Cells were
live-frozen in freezing medium (20% v/v DMSO; 80% v/v
Fetal Calf Serum (Lonza, Basel, Switzerland)) in aliquots.
For experiments requiring up to 4 × 107 cells per chroma-
tin preparation, two million thawed CD4+ cells were acti-
vated using Human T-Expander CD3/CD28 (Invitrogen,
Carlsbad, CA) according to manufacturers instructions
and cells were cultured in X-VIVO media (Lonza) supple-
mented with Interleukin II (10 ng/ul) for a period of two
weeks at 37°C in a humidified incubator under 5% CO2.
For experiments with human twin cell populations,
thawed CD4+ or CD8+ cells were used directly as input
into the ChIP procedure as detailed below.
Antibody selection
Polyclonal antisera against H3K4me3 (Diagenode s.a.,
Liège, Belgium; Cat. # pAb-003-050; Lot # A2-002P) and
H3K27me3 (Upstate Biotechnology, Temecula, CA;
Cat. # 07-449; Lot # DAM1387952) were selected after
screening several commercially available antisera for spe-
cificity using a custom histone peptide microarray (JPT
Peptide Technologies Gmbh, Berlin, Germany). Arrays
were spotted with 156 different selected peptides of
length 13 residues, representing covalently modified N-
terminal tails of H3 and H4 (details available upon re-
quest). Results of specificity testing are available in the
HisMAD database [36].
Chromatin immunoprecipitation
The method of Zhao and colleagues [21] was followed
and used as a benchmark to which our new method was
compared. The new method differs from the benchmark
in the following ways: (i) The requirement for dialysis
was removed by instead diluting chromatin in a concen-
trated immunoprecipitation buffer, allowing faster hand-
ling and reduced material loss. (ii) Sonication was
performed in a Bioruptor sonicator (Diagenode, Liège,
Belgium) using TPX plasticware to allow sonication of
small volumes with minimal sample loss and eliminate
potential sources of contamination. (iii) Control of
MNase Digestion was performed on a 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA) to allow visual-
isation of much lower DNA amounts. (iv) Illumina li-
brary preparation was altered to retain nucleosome-sized
fragments upon size selection, and (v) replace column-
based cleanup steps with SPRI-beads (Beckman Coulter,
Beverly, MA) to retain more DNA at every step.
The method is summarised below. In addition, a
detailed step-by-step method is provided as Additional
file 1. The method presented here is specifically tailored
for sequencing on Illumina technology, but should be
easily adaptable to other sequencing platforms. Cultured
CD4+ cells were counted, then harvested by centrifuga-
tion at 1500 × G for 5 mins at room temp and washed
in PBS. Cells were divided at this stage into separate
tubes according to the titration of starting cell numbers
required. Cell pellets were then resuspended in digestion
buffer (50 mM Tris–HCl, pH 8.0; 1 mM CaCl2; 0.2%
Triton X-100) at room temperature supplemented with
protease inhibitors. Because of impracticalities associated
with handling cell numbers spanning 3 orders of magni-
tude, it was not possible to use exactly the same volumes
and concentrations for all steps, and these differences
have been summarised in Table 4. Micrococcal nuclease
(USB, Cleveland, OH) was added to a concentration of
0.19 units per 1 × 107 cells, and incubated for 5 mins at
37°C. Digestion was terminated by the addition of 0.1
volumes of stop solution (110 mM Tris pH 8.0; 55 mM
EDTA) and samples transferred to ice. Samples were
then subjected to brief sonication in a Bioruptor (Diage-
node) for 60 seconds, on high power with no pulsing in
Gilfillan et al. BMC Genomics 2012, 13:645 Page 10 of 13
http://www.biomedcentral.com/1471-2164/13/645
TPX tubes (Diagenode) to assist with recovery of oligo-
nucleosomes. Samples were then adjusted to RIPA buffer
conditions by the addition of 1 volume 2xRIPA IP buffer
(280 mM NaCl; 1.8% Triton X-100; 0.2% SDS; 0.2% Na-
Deoxycholate; 5 mM EGTA) supplemented with
protease inhibitors, and spun in a microcentrifuge at
16,000 × G for 15 mins at 4°C. Supernatants were imme-
diately removed to fresh tubes and 10% volume removed
for DNA purification as “input”. DNA was later purified
from input samples by adding proteinase K (USB, Cleve-
land, OH) to a final concentration of 0.5 mg/ml and in-
cubating at 55°C for 1 hour, prior to purification over a
Genomic DNA cleanup & Concentrator column (Zymo
Research Corp., Irvine, CA). The size of input DNA was
then measured on a 2100 Bioanalyzer (Agilent Tech-
nologies) using high sensitivity reagents, to check
that all samples had similar digestion levels and
were primarily composed of mono-nucleosomes. The
remaining majority of the chromatin was immediately
used for immunoprecipitation. Chromatin was first pre-
cleared by the addition of a 1:1 mix of protein A and G
Dynabeads (Invitrogen, Carlsbad, CA) with rotation at
4°C for 1 hour (see Table 4). Chromatin was then
divided into two for specific IP with H3K4me3 or con-
trol IgG (see Table 4) and incubated overnight with rota-
tion, followed by immunoprecipitation with protein A
and G Dynabeads for 2 hours at 4°C. Beads were immo-
bilised on magnetic racks and the supernatants dis-
carded, after which the beads were washed five times
with RIPA buffer (10 mM Tris pH 8.0; 1 mM EDTA;
140 mM NaCl; 1% Triton X-100; 0.1% SDS; 0.1% Na-
Deoxycholate) and once with LiCl wash buffer (250 mM
LiCl; 10 mM Tris pH 8.0; 1 mM EDTA; 0.5% Igepal CA-
630; 0.5% Na-deoxycholate). All washes were carried out
for 5 mins at 4°C on a rotating wheel (see Table 4 for
volumes) in the presence of protease inhibitors. Beads
were finally rinsed with TE buffer without protease inhi-
bitors. Beads were then resuspended in 100 μl TE con-
taining 0.5 mg/ml proteinase K and incubated at 55°C for
1 hour with shaking, prior to purification over a purifica-
tion column as detailed for input DNA above, eluting in
50 μl 5 mM Tris buffer.
Real-time PCR
Two microliters of ChIP eluate were used per reaction
to control the success of the immunoprecipitations
using the following real-time PCR primer combina-
tions: H3K4me3 positive control locus TaqMan assay
(probe with 50 FAM and 30 blackhole quencher 1)
[RPL30-F CAAGGCAAAGCGAAATTGGT; RPL30-R
GCCCGTTCAGTCTCTTCGATT; RPL30-P TCTCGC
TAACAACTGCCCAGCTTTGAG], negative control
locus SYBR Green assay [NegC1-F ACGTACCTTA
AGCCCCTGGT; NegC1-R TAGTGCCTGGAGTGAG
GATG]. Primers were obtained from MWG Biotech
(Ebersberg, Germany), and reactions performed using
TaqMan or SYBR Green universal PCR master mixes
(Applied Biosystems, Foster City, CA).
Illumina library preparation
Twenty five microliters of immunoprecipitated or input
DNA (ranging from <1 ng – 4 ng DNA) was used for
library preparation using Illumina (San Diego, CA)
TruSeq™ DNA Sample Preparation reagents, with liga-
tion of 1/10th the manufacturers recommended adapter
amounts and agarose gel selection of DNA fragments in
the 200–500 bp size range.
High-throughput sequencing
Sequencing (36 bp single reads) was performed on an
Illumina Genome Analyzer IIx using v4 cluster gener-
ation and v3 sequencing reagents, using one lane per
sample. Yields varied within the range of 13.4 to 17.1
million reads passing filters per sample (0.48 – 0.62 Gb).
Alternatively, for additional sequencing of a single sam-
ple (ChIP from 2 × 104 cells) and for all ChIP experi-
ments using live-frozen human lymphocytes, libraries
were sequenced (50 bp single-end reads) on an Illumina
Table 4 Variable parameters applied to chromatin from different starting cell numbers
Protocol & starting cell
number
Benchmark New New New New New
4 x 107 4 x 107 5 x 106 1 x 106 2 x 105 4 x 104
Cells per IP 2 x 107 2 x 107 2.5 x 106 5 x 105 1 x 105 2 x 104
MNase digestion
volume (cells / ml)
1500 μl 1500 μl 500 μl 100 μl 20 μl 20 μl
(2.7 x 107/ml) (2.7 x 107/ml) (1 x 107 / ml) (1 x 107 / ml) (1 x 107 / ml) (2 x 106 / ml)
IP volume 750 μl 1500 μl 500 μl 100 μl 100 μl 100 μl
(in 1.5 ml tube) (in 2 ml tube) (in 1.5 ml tube) (in 0.2 ml PCR tube) (in 0.2 ml PCR tube) (in 0.2 ml PCR tube)
Protein A/G bead
volume for preclearing / IP
50 μl 50 μl 50 μl 10 μl 10 μl 10 μl
Antibody amount / IP 5μg 5μg 5μg 1 μg 1 μg 1 μg
Wash buffer volumes 1 ml 1 ml 1 ml 150 μl 150 μl 150 μl
“Benchmark” refers to the protocol now published by Zhao and colleagues [21] and “new” to the method presented here.
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HiSeq 2000 using TruSeq v2.0 clustering and SBS se-
quencing reagents. Samples run on the HiSeq 2000 were
indexed and run together, such that each sample
obtained reads equivalent to half a lane on the flow cell.
Data analysis
Illumina GAIIx image analysis and base calling was per-
formed using Illumina’s RTA software version 1.4 and
experiments performed on the Illumina HiSeq 2000
were analysed using RTA version 1.12. Reads were fil-
tered to remove those with low base call quality using
Illumina’s default chastity criteria. Reads were mapped
to the human reference genome (release hg18 / NCBI36)
using BWA version 0.5.9 with default settings [37]. Peak
calling was performed by MACS version 1.4 [26] using
shift size determined by the size of sequencing library
inserts, and switching off local background estimation
(as recommended for histone modification peak calling
in the absence of a control immunoprecipitation). Peak
calling was only based on reads mapping to a single lo-
cation, excluding duplicates. Manipulation of alignment
and peak files was performed using samtools version
0.1.15 [38] and bedtools version 2.11.2 [39] software. We
investigated the reproducibility of the protocol between
different samples by dividing the genome into non-
overlapping 10k or 50k bins and then computing the
number of uniquely mapping non-duplicate reads in
each bin. The count of reads in each bin was then nor-
malised for the sample’s total number of uniquely map-
ping non-duplicate reads. In order to visualise the same
data in a genome browser, we applied the count com-
mand of the igvtools utilities to the dataset of uniquely
mapping non-duplicate reads and displayed the result in
IGV using the heatmap setting [25].
Histone methylation levels surrounding gene start
positions
Gene expression data for CD4+ T lymphocytes was
obtained from the Gene Expression Omnibus[40] dataset
GSE473 [41]. Affymetrix microarray design U133A expres-
sion data was retrieved for 10 control individuals, from
which average gene expression levels were calculated and
used to assign genes to highest or lowest quartile expres-
sion categories. H3K4me3 ChIP read depth was calculated
2 kb upstream and downstream of gene start positions.
Additional file
Additional file 1: A detailed protocol of the native ChIP-seq
procedure described herein.
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